US NeuroSurgical Holdings Inc
Elite Health Systems Inc., through its subsidiaries, develops a business to provide Medicare Advantage plans and related services in California and Nevada. The company was formerly known as U.S. NeuroSurgical Holdings, Inc. and changed its name to Elite Health Systems Inc. in September 2024. Elite Health Systems Inc. was founded in 1993 and is headquartered in Ontario, California.
US NeuroSurgical Holdings Inc (USNU) - Net Assets
Latest net assets as of June 2025: $3.79 Million USD
Based on the latest financial reports, US NeuroSurgical Holdings Inc (USNU) has net assets worth $3.79 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.98 Million) and total liabilities ($197.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.79 Million |
| % of Total Assets | 95.06% |
| Annual Growth Rate | N/A |
| 5-Year Change | 13.35% |
| 10-Year Change | 77.18% |
| Growth Volatility | 110.35 |
US NeuroSurgical Holdings Inc - Net Assets Trend (1997–2024)
This chart illustrates how US NeuroSurgical Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for US NeuroSurgical Holdings Inc (1997–2024)
The table below shows the annual net assets of US NeuroSurgical Holdings Inc from 1997 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $4.18 Million | +547.75% |
| 2023-12-31 | $645.00K | -55.70% |
| 2022-12-31 | $1.46 Million | -56.24% |
| 2021-12-31 | $3.33 Million | -9.74% |
| 2020-12-31 | $3.69 Million | +16.90% |
| 2019-12-31 | $3.15 Million | +4.72% |
| 2018-12-31 | $3.01 Million | -12.27% |
| 2017-12-31 | $3.43 Million | +18.59% |
| 2016-12-31 | $2.89 Million | +22.73% |
| 2015-12-31 | $2.36 Million | +20.18% |
| 2014-12-31 | $1.96 Million | +40.04% |
| 2013-12-31 | $1.40 Million | -32.25% |
| 2012-12-31 | $2.07 Million | +54.44% |
| 2011-12-31 | $1.34 Million | +2.37% |
| 2010-12-31 | $1.31 Million | +55.90% |
| 2009-12-31 | $839.00K | +9.67% |
| 2008-12-31 | $765.00K | +0.53% |
| 2007-12-31 | $761.00K | -30.57% |
| 2006-12-31 | $1.10 Million | -7.04% |
| 2005-12-31 | $1.18 Million | -19.47% |
| 2004-12-31 | $1.46 Million | +9.50% |
| 2003-12-31 | $1.34 Million | -2.27% |
| 2002-12-31 | $1.37 Million | +6.96% |
| 2001-12-31 | $1.28 Million | +13.09% |
| 2000-12-31 | $1.13 Million | -1.74% |
| 1999-12-31 | $1.15 Million | +210.35% |
| 1998-12-31 | $-1.04 Million | -60.46% |
| 1997-12-31 | $-650.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to US NeuroSurgical Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 367500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $200.00K | 4.79% |
| Other Comprehensive Income | $238.00K | 5.70% |
| Other Components | $8.19 Million | 195.91% |
| Total Equity | $4.18 Million | 100.00% |
US NeuroSurgical Holdings Inc Competitors by Market Cap
The table below lists competitors of US NeuroSurgical Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VOLT RESOURCES LTD
F:R8L
|
$11.51 Million |
|
Taiwan Chelic Corp Ltd
TW:4555
|
$11.52 Million |
|
Desoto Resources Ltd
AU:DES
|
$11.52 Million |
|
Bioqual Inc
PINK:BIOQ
|
$11.52 Million |
|
Harbor Bankshares Corporation
PINK:HRBK
|
$11.51 Million |
|
IKTINOS HELLAS NA EO 010
F:F40
|
$11.51 Million |
|
Aplisens SA
WAR:APN
|
$11.51 Million |
|
NANOBRICK Co. Ltd
KQ:286750
|
$11.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in US NeuroSurgical Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 645,000 to 4,178,000, a change of 3,533,000 (547.8%).
- Net loss of 2,055,000 reduced equity.
- Share repurchases of 355,000 reduced equity.
- New share issuances of 5,175,000 increased equity.
- Other comprehensive income increased equity by 238,000.
- Other factors increased equity by 530,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.06 Million | -49.19% |
| Share Repurchases | $355.00K | -8.5% |
| Share Issuances | $5.17 Million | +123.86% |
| Other Comprehensive Income | $238.00K | +5.7% |
| Other Changes | $530.00K | +12.69% |
| Total Change | $- | 547.75% |
Book Value vs Market Value Analysis
This analysis compares US NeuroSurgical Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.58x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $-0.20 | $0.70 | x |
| 1999-12-31 | $0.16 | $0.70 | x |
| 2000-12-31 | $0.15 | $0.70 | x |
| 2001-12-31 | $0.18 | $0.70 | x |
| 2002-12-31 | $0.18 | $0.70 | x |
| 2003-12-31 | $0.17 | $0.70 | x |
| 2004-12-31 | $0.19 | $0.70 | x |
| 2005-12-31 | $0.15 | $0.70 | x |
| 2006-12-31 | $0.14 | $0.70 | x |
| 2007-12-31 | $0.10 | $0.70 | x |
| 2008-12-31 | $0.10 | $0.70 | x |
| 2009-12-31 | $0.11 | $0.70 | x |
| 2010-12-31 | $0.17 | $0.70 | x |
| 2011-12-31 | $0.17 | $0.70 | x |
| 2012-12-31 | $0.27 | $0.70 | x |
| 2013-12-31 | $0.18 | $0.70 | x |
| 2014-12-31 | $0.25 | $0.70 | x |
| 2015-12-31 | $0.30 | $0.70 | x |
| 2016-12-31 | $0.37 | $0.70 | x |
| 2017-12-31 | $0.44 | $0.70 | x |
| 2018-12-31 | $0.39 | $0.70 | x |
| 2019-12-31 | $0.40 | $0.70 | x |
| 2020-12-31 | $0.47 | $0.70 | x |
| 2021-12-31 | $0.36 | $0.70 | x |
| 2022-12-31 | $0.16 | $0.70 | x |
| 2023-12-31 | $0.07 | $0.70 | x |
| 2024-12-31 | $0.27 | $0.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently US NeuroSurgical Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -49.19%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.03x
- Recent ROE (-49.19%) is below the historical average (-10.51%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 0.00% | -43.35% | 0.40x | 0.00x | $-906.70K |
| 1999 | 5.73% | 2.14% | 0.58x | 4.59x | $-49.10K |
| 2000 | -1.50% | -0.66% | 0.53x | 4.29x | $-130.10K |
| 2001 | 9.38% | 4.66% | 0.68x | 2.97x | $-7.90K |
| 2002 | 7.16% | 3.71% | 0.89x | 2.17x | $-38.80K |
| 2003 | 4.56% | 2.50% | 0.78x | 2.36x | $-72.70K |
| 2004 | 8.40% | 5.12% | 0.57x | 2.87x | $-23.40K |
| 2005 | -24.17% | -13.52% | 0.45x | 3.96x | $-402.90K |
| 2006 | -34.95% | -19.13% | 0.57x | 3.19x | $-492.60K |
| 2007 | -44.02% | -20.45% | 0.62x | 3.47x | $-411.10K |
| 2008 | 0.52% | 0.23% | 0.80x | 2.87x | $-72.50K |
| 2009 | 8.58% | 3.18% | 0.45x | 6.02x | $-11.90K |
| 2010 | 35.86% | 18.34% | 0.53x | 3.68x | $338.20K |
| 2011 | 2.17% | 1.41% | 0.49x | 3.11x | $-104.90K |
| 2012 | 35.25% | 37.27% | 0.37x | 2.56x | $522.20K |
| 2013 | -47.61% | 0.00% | -0.01x | 1.48x | $-807.10K |
| 2014 | 28.59% | 21.52% | 0.35x | 3.80x | $364.80K |
| 2015 | 16.79% | 13.33% | 0.40x | 3.13x | $160.20K |
| 2016 | 18.52% | 16.69% | 0.39x | 2.85x | $246.60K |
| 2017 | 15.68% | 15.76% | 0.43x | 2.31x | $194.80K |
| 2018 | -13.98% | -12.30% | 0.55x | 2.06x | $-722.10K |
| 2019 | 4.50% | 4.63% | 0.61x | 1.58x | $-173.30K |
| 2020 | 14.46% | 16.80% | 0.76x | 1.13x | $164.40K |
| 2021 | -31.13% | -83.03% | 0.29x | 1.30x | $-1.16 Million |
| 2022 | -126.88% | 0.00% | 0.00x | 1.41x | $-1.70 Million |
| 2023 | -126.51% | 0.00% | 0.00x | 2.05x | $-880.50K |
| 2024 | -49.19% | 0.00% | 0.00x | 1.03x | $-2.47 Million |
Industry Comparison
This section compares US NeuroSurgical Holdings Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $217,614,372
- Average return on equity (ROE) among peers: -3.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| US NeuroSurgical Holdings Inc (USNU) | $3.79 Million | 0.00% | 0.05x | $11.51 Million |
| Addus HomeCare Corporation (ADUS) | $158.93 Million | 7.57% | 0.45x | $1.75 Billion |
| agilon health Inc (AGL) | $661.02 Million | -39.73% | 1.63x | $159.70 Million |
| Airsculpt Technologies Inc (AIRS) | $70.77 Million | -20.74% | 1.84x | $17.23 Million |
| Amedisys Inc (AMED) | $51.40 Million | 16.36% | 0.80x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $67.07 Million | -7.75% | 2.12x | $624.22 Million |
| American Shared Hospital Service (AMS) | $22.75 Million | -0.83% | 1.66x | $7.78 Million |
| American Oncology Network Inc. (AONC) | $62.02 Million | 4.17% | 4.26x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $218.68 Million |
| Arem Pacific Corporation (ARPC) | $-45.19K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $-82.09K | 0.00% | 0.00x | $1.07 Billion |